Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002273649 | SCV002558535 | uncertain significance | not provided | 2022-01-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002273649 | SCV003460211 | benign | not provided | 2024-10-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047493 | SCV004946266 | uncertain significance | Inborn genetic diseases | 2023-10-17 | criteria provided, single submitter | clinical testing | The c.4619C>T (p.P1540L) alteration is located in exon 6 (coding exon 5) of the SETBP1 gene. This alteration results from a C to T substitution at nucleotide position 4619, causing the proline (P) at amino acid position 1540 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |